IPW
PCVX icon

Impact Partnership Wealth’s Vaxcyte PCVX Stock Holding History

Impact Partnership Wealth’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-29
Closed -$1.45K – 1147
2023
Q2 		$1.45K Buy
+29
New +$1.38K ﹤0.01% 740

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Impact Partnership Wealth's PCVX Position: Q3 2023 in Review

Impact Partnership Wealth sold out of Vaxcyte (PCVX) in Q3 2023, closing a stake of 29 shares — an estimated $1.45K sold.

Impact Partnership Wealth first reported a position in PCVX in Q2 2023 and held it in 1 quarter. The position peaked at $1.45K in Q2 2023. 202 funds tracked by Wall St. Rank hold PCVX as of Q3 2023.

  • Impact Partnership Wealth reported no remaining Vaxcyte position as of Q3 2023 after selling out during the quarter.
  • Impact Partnership Wealth sold 29 Vaxcyte shares in Q3 2023, an estimated $1.45K.
  • Impact Partnership Wealth first reported a position in Vaxcyte in Q2 2023 and held it in 1 quarter.
  • Impact Partnership Wealth's Vaxcyte position peaked at $1.45K in Q2 2023.
  • 202 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2023.

Based on Impact Partnership Wealth's 13F filing for Q3 2023, filed 17 Oct 2023.